The transforming growth factor β (TGF-β) pathway plays an important, context-dependent role as both a tumor suppressor and a promoter of PDAC and is altered in 47% of PDAC cases (Bailey et al., 2016; Dardare et al., 2020). Here, TGFB1 is linked to neoplasm.